<--- Back to Details
First PageDocument Content
Diabetes / Peptide hormones / Biology / Eli Lilly and Company / Pancreatic hormones / Liraglutide / Incretin / Glucagon-like peptide-1 / Anti-diabetic medication / Endocrine system / Medicine / Anti-diabetic drugs
Diabetes
Peptide hormones
Biology
Eli Lilly and Company
Pancreatic hormones
Liraglutide
Incretin
Glucagon-like peptide-1
Anti-diabetic medication
Endocrine system
Medicine
Anti-diabetic drugs

12933_2015_206_Article 1..11

Add to Reading List

Source URL: www.cardiab.com

Download Document from Source Website

File Size: 1,91 MB

Share Document on Facebook

Similar Documents

Biology / Peptide hormones / Anti-diabetic drugs / Eli Lilly and Company / Pancreatic hormones / Glucagon-like peptide-1 / Glucagon / Anti-diabetic medication / Incretin / Endocrine system / Diabetes / Medicine

exploring the role of glucagon in glucose homeostasis exploring the role of glucagon in glucose homeostasis

DocID: 1fV20 - View Document

Research article Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice Benjamin J. Lamont,1 Yazhou Li,1 Edwin Kwan,2 Theodore J. Brown,3

DocID: 1drh2 - View Document

Innovatie Programma Samenvatting toegekend project Versie:2 augustus 2010 Titel: The gut-kidney axis: are incretin-based therapies protective in human diabetic kidney disease?

DocID: 1cnJ1 - View Document

Pharmacy / Pharmacology / Formulary / Fax / Science / Pharmaceutical sciences / Pharmaceuticals policy / Technology

Pharmacy Services: Incretin Mimetics Step Fax-back Sheet

DocID: 17YB6 - View Document

Anti-diabetic drugs / Medicine / Diabetes / Eli Lilly and Company / Pancreatic hormones / Glucagon-like peptide-1 / Incretin / Glucagon / Insulin / Peptide hormones / Endocrine system / Biology

PDF Document

DocID: 17dZM - View Document